Concepedia

Longwen Xu

LX

Statistics

Publications

10

Citations

439

H-Index

10

Active since

2016

Affiliations

Peking University(Current)

Peking University Cancer Hospital

First Affiliated Hospital of Xi'an Jiaotong University

Air Force Medical University

Ministry of Education

Longwen Xu is an author at Peking University specializing in medicine, oncology, and molecular oncology.

Publications per year

2016–2022

10

Publications

10

Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients

Jiayi Yu, Xiaowen Wu, Junya Yan et al. · Journal of Hematology & Oncology · 2018 · 187 citations · Full text

, , +17

miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy

Huan Tang, Meng Ma, Jie Dai et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 59 citations · Full text

, , +17

Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy

Longwen Xu, Zhiyuan Cheng, Chuanliang Cui et al. · Journal of Translational Medicine · 2019 · 40 citations · Full text

, , +17

Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy

Huan Yu, Meng Ma, Junya Yan et al. · Journal of Translational Medicine · 2017 · 37 citations · Full text

, , +17

Inhibition of miR-7 promotes angiogenesis in human umbilical vein endothelial cells by upregulating VEGF via KLF4

Yize Li, Lei Wen, Wei Xu et al. · Oncology Reports · 2016 · 30 citations · Full text

, , +8

1–5 of 10